Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer

Gut

Volumn 64, Issue 4, 2015, Pages 636-645

  Yu, Jun ^a   Wu, William K K ^a   Li, Xiangchun ^a,b   He, Jun ^a,b   Li, Xiao Xing ^a   Ng, Simon S M ^a   Yu, Chang ^a,b   Gao, Zhibo ^a,b   Yang, Jie ^b   Li, Miao ^b   Wang, Qiaoxiu ^b   Liang, Qiaoyi ^a   Pan, Yi ^a   Tong, Joanna H ^a   To, Ka F ^a   Wong, Nathalie ^a   Zhang, Ning ^a,c   Chen, Jie ^c   Lu, Youyong ^d   Lai, Paul B S ^a   Chan, Francis K L ^a   Li, Yingrui ^b   Kung, Hsiang Fu ^a   Yang, Huanming ^b   Wang, Jun ^b   Sung, Joseph J Y ^a   more..

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b BGI SHENZHEN   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

APC GENE; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CDH10 GENE; CELL CYCLE ARREST; COL6A3 GENE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; DOCK2 GENE; FAT4 GENE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; HYDROLYSIS; KRAS GENE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; NEXT GENERATION SEQUENCING; ONCOGENE; OVERALL SURVIVAL; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SMAD4 GENE; SOMATIC MUTATION; SURVIVAL TIME; TMEM132D GENE; TP53 GENE; VCAN GENE; COLORECTAL TUMOR; EXOME; GENETICS; MUTATION; PROGNOSIS;

COLORECTAL NEOPLASMS; EXOME; FEMALE; HUMANS; MALE; MUTATION; PROGNOSIS;

EID: 84924407954     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-306620     Document Type: Article

References (38)

1. Sung JJ, Lau JY, Goh KL, et al. Asia Pacific Working Group on Colorectal C. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005;6:871-6.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
3. Woodford-Richens KL, Rowan AJ, Gorman P, et al. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway. Proc Natl Acad Sci U S A 2001;98:9719-23.
4. Wong SH, Sung JJ, Chan FK, et al. Genome-wide association and sequencing studies on colorectal cancer. Semin Cancer Biol 2013;23:502-11.
5. Sjöblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268-74.
6. Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-13.
7. The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-7.
8. Wu WK, Wang XJ, Cheng AS, et al. Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis. Crit Rev Oncol Hematol 2013;86:251-77.
9. Benson AB 3rd, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004;22:3408-19.
10. Weiser MR, Gönen M, Chou JF, et al. Predicting survival after curative colectomy for cancer: individualizing colon cancer staging. J Clin Oncol 2011;29:4796-802.
11. Merok MA, Ahlquist T, Røyrvik EC, et al. Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann Oncol 2013;24:1274-82.
12. Samowitz WS, Sweeney C, Herrick J, et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 2005;65:6063-9.
13. Nannini M, Pantaleo MA, Maleddu A, et al. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treat Rev 2009;35:201-9.
14. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009;25:1754-60.
15. Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009;25:2078-9.
16. McKenna A, Hanna M, Banks E, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;20:1297-303.
17. Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 2013;31:213-19.
18. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010;38:e164.
19. Koboldt DC, Zhang Q, Larson DE, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 2012;22:568-76.
20. Kan Z, Jaiswal BS, Stinson J, et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010;466:869-73.
21. Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012;489:519-25.
22. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014;507:315-22.
23. Gonzalez-Perez A, Lopez-Bigas N. Functional impact bias reveals cancer drivers. Nucleic Acids Res 2012;40:e169.
24. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997;275:1787-90.
25. Dasgupta B, Li W, Perry A, et al. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes. Cancer Res 2005;65:236-45.
26. Cho KR, Oliner JD, Simons JW, et al. The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 1994;19:525-31.
27. Watanabe Y, Castoro RJ, Kim HS, et al. Frequent alteration of MLL3 frameshift mutations in microsatellite deficient colorectal cancer. PLoS One 2011;6:e23320.
28. Marra G, Schär P. Recognition of DNA alterations by the mismatch repair system. Biochem J 1999;338:1-13.
29. Pan G, Feng Y, Ambegaonkar AA, et al. Signal transduction by the Fat cytoplasmic domain. Development 2013;140:831-42.
30. Qi C, Zhu YT, Hu L, et al. Identification of Fat4 as a candidate tumor suppressor gene in breast cancers. Int J Cancer 2009;124:793-98.
31. Rauch TA, Wang Z, Wu X, et al. DNA methylation biomarkers for lung cancer. Tumour Biol 2012;33:287-96.
32. Nikolaev SI, Rimoldi D, Iseli C, et al. Exome sequencing identifi es recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet 2012;44:133-9.
33. Zang ZJ, Cutcutache I, Poon SL, et al. Exome sequencing of gastric aenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet 2012;44:570-74.
34. Shimoyama Y, Tsujimoto G, Kitajima M, et al. Identification of three human type-II classic cadherins and frequent heterophilic interactions between different subclasses of type-II classic cadherins. Biochem J 2000;349:159-67.
35. Walker MM, Ellis SM, Auza MJ, et al. The intercellular adhesion molecule, cadherin-10, is a marker for human prostate luminal epithelial cells that is not expressed in prostate cancer. Mod Pathol 2008;21:85-95.
36. Myant KB, Cammareri P, McGhee EJ, et al . ROS Production and NF-kappaB Activation Triggered by RAC1 Facilitate WNT-Driven Intestinal Stem Cell Proliferation and Colorectal Cancer Initiation. Cell Stem Cell 2013;12: 761-73.
37. Zhu G, Wang Y, Huang B, et al. A Rac1/PAK1 cascade controls beta-catenin activation in colon cancer cells. Oncogene 2012;31:1001-12.
38. Dulak AM, Stojanov P, Peng S, et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet 2013;45:478-86.